Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 3/20 | 0.33 |
| ▸ | GSK3A | P49840 | 1/20 | 0.33 |
| ▸ | GSK3B | P49841 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | BLM | P54132 | 2/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | WRN | Q14191 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
| ▸ | GMNN | O75496 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | THPO | P40225 | 1/20 | 0.30 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10022757 | 0.74 | SLC1A2 (0.33) | ALDH1A1 | |
| SCHEMBL13742892 | 0.69 | MGLL (0.41) | MGLLGSK3AGSK3BALDH1A1BLM | |
| SCHEMBL331187 | 0.69 | MGLL (0.41) | MGLLGSK3AGSK3BALDH1A1BLM | |
| SCHEMBL13968985 | 0.69 | MGLL (0.41) | MGLLGSK3AGSK3BALDH1A1BLM | |
| SCHEMBL29017 | 0.68 | MGLL (0.45) | MGLLGSK3AGSK3BALDH1A1BLM | |
| SCHEMBL43978 | 0.68 | MGLL (0.45) | MGLLGSK3AGSK3BALDH1A1BLM | |
| SCHEMBL17924908 | 0.67 | MGLL (0.35) | MGLLGSK3AGSK3BALDH1A1BLM | |
| SCHEMBL17924943 | 0.67 | MGLL (0.35) | MGLLGSK3AGSK3BALDH1A1BLM | |
| SCHEMBL17924834 | 0.67 | MGLL (0.35) | MGLLGSK3AGSK3BALDH1A1BLM | |
| SCHEMBL17924892 | 0.65 | MGLL (0.38) | MGLLGSK3AGSK3BALDH1A1BLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8476461-B2 | Dipyrromethene-boron hydrophilic fluorescent compounds | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.) (FR) | 2013-07-02 | — | — | US | disclosed |
| US-20120009615-A1 | DIPYRROMETHENE-BORON HYDROPHILIC FLUORESCENT COMPOUNDS | UNIVERSITE DE STRASBOURG (50% PART INTEREST) (FR) | 2012-01-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120009615-A1 | DIPYRROMETHENE-BORON HYDROPHILIC FLUORESCENT COMPOUNDS | LDHB, AHR, BCR | MGLL 3908/4885GSK3A 4667/4885GSK3B 4545/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.